Compass Pathways
Compass Pathways is a biotechnology company developing psilocybin therapy for patients with mental health challenges. The company is currently conducting clinical research on its lead investigational treatment, COMP360, for conditions including treatment-resistant depression, post-traumatic stress disorder, and anorexia nervosa. Their approach integrates psychopharmacology with digital technologies and psychotherapy to improve patient outcomes.
Biotechnology
Healthcare
Mental Health
Healthtech
Funding summary
- Total raised
- €336.0M
- Funding rounds
- 2
Investors in Compass Pathways
Investors on record for Compass Pathways. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Compass Pathways?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors